Noble Capital Markets Initiates Equity Research Coverage on GeoVax Labs Inc. (GOVX)
Noble’s Equity Research Analyst Robert LeBoyer launched coverage on GeoVax Labs, Inc. today with his report titled "Initiating Coverage With $6 Price Target"
Noble’s Equity Research Analyst Robert LeBoyer launched coverage on GeoVax Labs, Inc. today with his report titled "Initiating Coverage With $6 Price Target"
